Recursion Pharmaceuticals Inc (RXRX)
A research Signal Score of unusual activity and the signals behind it. Not advice, not a prediction, not yet backtested.
14/100
Low signalSIGNAL SCORE
P(beat S&P 500 · next 20 sessions)46%
Our last 30 days of resolved calls came true 33% of the time.See the track record →
Price
$4.70
1 day
+14.08%
1 week
+11.35%
1 month
-0.24%
1 year
-25.36%
Market cap
$2.2B
Company fundamentals
EPS (TTM)
$-1.04
Debt / Equity
0.02
Current ratio
5.03
Operating margin
-991.7%
Net margin
-945.9%
Gross margin
3.5%
Return on equity
-50.4%
Revenue growth (YoY)
-15.1%
Figures reflect the most recent reported period. Margins, ROE and growth are percentages; Debt/Equity and Current ratio are ratios.
Example trade plan · illustrative risk framework
Entry zone
$4.63–$4.79
Stop-loss (exit)
$4.23 −10%
Target (exit)
$5.64 +20%
A generic 2:1 reward-to-risk example (about a 10% stop and 20% target). Illustrative and educational, not advice. Set your own levels for your risk tolerance.
Why it ranks: factor attribution
- Session momentumUp 14.1% on the session+14
- Weekly momentum+11.4% over the past week+11
- QualityRevenue shrinking (-15% y/y)-11
- VolumeNo intraday volume on the free data tier — this factor is disabled, not faked.+0
Score uses live volume/momentum/breakout signals today; insider buying, short interest, options flow and social velocity layer in as those sources come online. How it works →